blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2056802

EP2056802 - ANTI-DIABETES COMPOSITION CONTAINING CHICORIC ACID AND/OR ONE OF THE METABOLITES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.01.2014
Database last updated on 15.06.2024
Most recent event   Tooltip17.07.2015Lapse of the patent in a contracting state
New state(s): HU, LU		published on 19.08.2015  [2015/34]
Applicant(s)For all designated states
Centre National de la Recherche Scientifique (C.N.R.S.)
3, rue Michel-Ange
75016 Paris / FR
[N/P]
Former [2009/20]For all designated states
Centre National de la Recherche Scientifique (CNRS)
3, rue Michel-Ange
75116 Paris / FR
Inventor(s)01 / ANDARY, Claude
17 rue des Millepertuis
F-34830 Clapiers / FR
02 / RIBES, Gérard
42 route de Lavérune
F-34070 Montpellier / FR
03 / TOUSCH, Didier
383 rue Pioch de Boutonnet
Résidence La Traversière Bât. A
F-34090 Montpellier / FR
04 / AZAY-MILHAU, Jacqueline
Lotissement "Les clairières"
36 rue du Val de la Mosson
34430 Saint Jean de Vedas / FR
05 / LAJOIX, Anne-Dominique
145 Impasse de la voie Romaine
Bat B, App 107
34090 Montpellier / FR
 [2012/39]
Former [2009/36]01 / ANDARY, Claude
17 rue des Millepertuis
F-34830 Clapiers / FR
02 / RIBES, Gérard
42 route de Lavérune
F-34070 Montpellier / FR
03 / TOUSCH, Didier
383 rue Pioch de Boutonnet Résidence La Traversière Bât. A
F-34090 Montpellier / FR
04 / AZAY-MILHAU, Jacqueline
Lotissement "Les clairières", 36 rue du Val de la Mosson
34430 SAINT JEAN DE VEDAS / FR
05 / LAJOIX, Anne-Dominique
145 Impasse de la voie Romaine, Bat B, App 107
34090 MONTPELLIER / FR
Former [2009/20]01 / ANDARY, Claude
17 rue des Millepertuis
F-34830 Clapiers / FR
02 / RIBES, Gérard
42 route de Lavérune
F-34070 Montpellier / FR
03 / TOUSCH, Didier
383 rue Pioch de Boutonnet Résidence La Traversière Bât. A
F-34090 Montpellier / FR
Representative(s)Regimbeau
20, rue de Chazelles
75847 Paris Cedex 17 / FR
[2012/49]
Former [2012/30]Faivre Petit, Frédérique, et al
Cabinet Regimbeau 20, rue de Chazelles
75847 Paris Cedex 17 / FR
Former [2009/49]Warcoin, Jacques, et al
Cabinet Régimbeau 20, rue de Chazelles
75847 Paris Cedex 17 / FR
Former [2009/20]Warcoin, Jacques, et al
Cabinet Régimbeau 20, rue de Chazelles
75847 Paris Cedex 17 / FR
Application number, filing date07802689.517.08.2007
[2009/20]
WO2007EP58580
Priority number, dateFR2006000738218.08.2006         Original published format: FR 0607382
[2009/20]
Filing languageFR
Procedural languageFR
PublicationType: A2 Application without search report
No.:WO2008022974
Date:28.02.2008
Language:FR
[2008/09]
Type: A2 Application without search report 
No.:EP2056802
Date:13.05.2009
Language:FR
The application published by WIPO in one of the EPO official languages on 28.02.2008 takes the place of the publication of the European patent application.
[2009/20]
Type: B1 Patent specification 
No.:EP2056802
Date:13.03.2013
Language:FR
[2013/11]
Search report(s)International search report - published on:EP04.12.2008
ClassificationIPC:A61K31/05, A61K31/192, A61K31/194, A61K31/225, A23L1/30, A61K31/7004, A61P3/10, A61P3/06, A61P3/04, A61P9/12
[2009/20]
CPC:
A61K31/225 (EP,US); A23L33/105 (EP,US); A61K31/05 (EP,US);
A61K31/192 (EP,US); A61K31/194 (EP,US); A61K31/7004 (EP,US);
A61P3/00 (EP); A61P3/04 (EP); A61P3/06 (EP);
A61P3/10 (EP); A61P9/12 (EP) (-)
C-Set:
A61K31/05, A61K2300/00 (EP,US);
A61K31/192, A61K2300/00 (US,EP);
A61K31/194, A61K2300/00 (US,EP);
A61K31/225, A61K2300/00 (US,EP);
A61K31/7004, A61K2300/00 (EP,US)
(-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/20]
TitleGerman:ANTI-DIABETES-ZUSAMMENSETZUNG MIT CHICOREE-SÄURE UND/ODER EINEM IHRER METABOLITEN[2009/20]
English:ANTI-DIABETES COMPOSITION CONTAINING CHICORIC ACID AND/OR ONE OF THE METABOLITES THEREOF[2009/20]
French:COMPOSITION ANTIDIABETIQUE CONTENANT DE L'ACIDE CHICORIQUE ET/OU L'UN DE SES MÉTABOLITES[2009/20]
Entry into regional phase17.03.2009National basic fee paid 
17.03.2009Designation fee(s) paid 
17.03.2009Examination fee paid 
Examination procedure17.03.2009Examination requested  [2009/20]
30.04.2009Amendment by applicant (claims and/or description)
05.02.2010Despatch of a communication from the examining division (Time limit: M06)
09.08.2010Reply to a communication from the examining division
24.08.2011Despatch of a communication from the examining division (Time limit: M06)
02.03.2012Reply to a communication from the examining division
31.08.2012Communication of intention to grant the patent
27.12.2012Fee for grant paid
27.12.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  05.02.2010
Opposition(s)16.12.2013No opposition filed within time limit [2014/08]
Fees paidRenewal fee
17.03.2009Renewal fee patent year 03
31.08.2010Renewal fee patent year 04
30.08.2011Renewal fee patent year 05
27.08.2012Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU17.08.2007
AT13.03.2013
CY13.03.2013
CZ13.03.2013
DK13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
MC13.03.2013
MT13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
TR13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
IE17.08.2013
LU17.08.2013
BE31.08.2013
[2015/34]
Former [2015/32]AT13.03.2013
CY13.03.2013
CZ13.03.2013
DK13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
MC13.03.2013
MT13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
TR13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
IE17.08.2013
BE31.08.2013
Former [2014/33]AT13.03.2013
CY13.03.2013
CZ13.03.2013
DK13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
MC13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
IE17.08.2013
BE31.08.2013
Former [2014/26]AT13.03.2013
CY13.03.2013
CZ13.03.2013
DK13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
MC13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
BE31.08.2013
Former [2014/20]AT13.03.2013
CY13.03.2013
CZ13.03.2013
DK13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
MC13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
Former [2014/09]AT13.03.2013
CY13.03.2013
CZ13.03.2013
DK13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
Former [2013/52]AT13.03.2013
CY13.03.2013
CZ13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
Former [2013/50]AT13.03.2013
CZ13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
NL13.03.2013
PL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
Former [2013/49]AT13.03.2013
CZ13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
NL13.03.2013
RO13.03.2013
SE13.03.2013
SI13.03.2013
SK13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
Former [2013/48]AT13.03.2013
EE13.03.2013
FI13.03.2013
LT13.03.2013
LV13.03.2013
NL13.03.2013
SE13.03.2013
SI13.03.2013
BG13.06.2013
GR14.06.2013
IS13.07.2013
PT15.07.2013
Former [2013/47]FI13.03.2013
LT13.03.2013
LV13.03.2013
SE13.03.2013
SI13.03.2013
BG13.06.2013
GR14.06.2013
PT15.07.2013
Former [2013/38]FI13.03.2013
LT13.03.2013
LV13.03.2013
SE13.03.2013
SI13.03.2013
BG13.06.2013
GR14.06.2013
Former [2013/37]FI13.03.2013
LT13.03.2013
SE13.03.2013
SI13.03.2013
BG13.06.2013
GR14.06.2013
Former [2013/34]LT13.03.2013
SE13.03.2013
BG13.06.2013
Former [2013/33]LT13.03.2013
Cited inInternational search[X]JP2005314435  ;
 [X]JP2002275058  ;
 [X]DE1949822  (SEDLACEK FERDINAND) [X] 1-5,7-9,14-18,20 * page 2, paragraphs 3-6 * * claim 1 *;
 [X]JPS61171418  ;
 [X]JP2003116486  ;
 [X]FR2638967  (ANDARY CLAUDE [FR]) [X] 15-18 * page 1, lines 1-30 * * page 2, lines 26-31 * * page 5, lines 14-24 * * claims 1,4 *;
 [X]WO02064536  (AGRONOMIQUE INST NAT RECH [FR], et al) [X] 15-17 * page 4, lines 21-26 * * page 7, line 28 - page 8, line 3 * * page 8, lines 31-33 * * page 15, lines 25-29 * * claims 24,25,31 *;
 [X]WO03029183  (UNIV BORDEAUX 1 [FR], et al) [X] 15-18 * page 1, lines 4-29 * * page 7, lines 4-12 * * page 8, line 25 - page 9, line 4 * * claims 18-21 *;
 [X]EP1559421  (KAO CORP [JP]) [X] 15-18 * page 3, paragraphs 12,15-19 * * page 4, paragraphs 22-25 * * page 5, paragraphs 38,40,41,43 * * claim 1 *;
 [X]WO0015215  (KOREA RESEARCH INST OF BIOSCIE [KR]) [X] 1,3,10-12,14-18,20 * page 1, lines 6-16 * * page 3, line 36 - page 5, line 4 * * page 5, line 36 - page 8, line 6 * * page 8, lines 20-29 * * page 8, line 37 - page 9, line 4 * * page 9, lines 13-29 * * claim - * * examples 7,Formulation1-3 *;
 [X]US2004043057  (SUZUKI ATSUSHI [JP], et al) [X] 1,3,14-18,20 * page 1, paragraphs 10-16 * * page 2, paragraphs 21,22 * * pages 2-3, paragraphs 26-30 * * page 3, paragraphs 33-36 * * examples 3-5 * * claims 1,6-10,14,17,18 *;
 [X]JPS6140763  (OSAKA CHEM LAB) [X] 1,3,14-18,20 * abstract *;
 [X]US2004192773  (SUZUKI ATSUSHI [JP], et al) [X] 1,3,10-12,14-18,20 * page 1, paragraph 7 - page 2, paragraph 12 * * page 2, paragraph 18 * * page 3, paragraphs 27,30,32 * * page 4, paragraphs 37-40 * * page 5, paragraph 67 * * example 5 * * claim 1 *;
 [X]US2006069161  (LEE MARGARET S [US], et al) [X] 1-7,9,10,14-18,20 * page 1, paragraphs 8,10 * * page 3, paragraph 31 * * page 10, paragraph 56 * * page 12, paragraph 77 * * page 14, paragraph 103 - page 15, paragraph 104 * * page 16, paragraph 111 * * example 1 * * claims 1,62,65 *;
 [X]WO0047045  (ZYLEPSIS LTD [GB], et al) [X] 15-18 * page 1, lines 4-8 * * page 2, lines 5-20 * * page 3, lines 1-4 * * page 4, lines 26-28 * * page 8, lines 9-11 * * page 11, lines 18-21 * * examples 7-10 * * page 48, lines 26-28 * * table 16 * * claims 1,7,8 *
 [X]  - NOMURA EISAKU ET AL, "Synthesis of amide compounds of ferulic acid, and their stimulatory effects on insulin secretion in vitro.", BIOORGANIC AND MEDICINAL CHEMISTRY, (20030815), vol. 11, no. 17, ISSN 0968-0896, pages 3807 - 3813, XP002425367 [X] 1-5,7,9,14-18,20 * page 3807, column 2, paragraph 1 - page 3808, column 2, paragraph 1 * * page 3809, column 1, paragraph 2 * * figures 1,3 * * page 3810, column 1, paragraph 1 *

DOI:   http://dx.doi.org/10.1016/S0968-0896(03)00280-3
 [X]  - OHNISHI M ET AL, "Antioxidant activity and hypoglycemic effect of ferulic acid in STZ-induced diabetic mice and KK-Ay mice", BIOFACTORS, (2004), vol. 21, no. 1-4, ISSN 0951-6433, pages 315 - 319, XP008076266 [X] 1-9,14-18,20 * abstract * * page 315, paragraph 1 - page 316, paragraph 4 * * page 316, paragraph L - page 319, paragraph 2 * * figures 1,2 *
 [X]  - TAGASHIRA EIJIRO ET AL., "Cardiovascular disease medicine and health food", DATABASE WPI, 0, Derwent World Patents Index, (20051110), no. 20, Database accession no. 2005-763566, page 8, XP002425373 & JP2005314435 A 20051110 (TAGASHIRA EIJIRO) [X] 1,3-5,14-18,20 * column A *
 [X]  - CHIKUNO T ET AL., "Hypoglycemic agent", DATABASE WPI, 0, Derwent World Patents Index, (20020925), no. 20, Database accession no. 2003-345667, page 3, XP002425374 & JP2002275058 A 20020925 (MORISHITA H ET AL.) [X] 1-9,14-18,20 * column A *
 [X]  - JUNG UN JU ET AL, "Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, (200608), vol. 318, no. 2, ISSN 0022-3565, pages 476 - 483 URL, XP008076265 [X] 1-5,7-9,14-18,20 * abstract * * page 477, column 1, paragraphs 1-3 * * page 478, column 2, paragraphs 3,4 * * figure 1 * * table 1 * * page 480, column 2, paragraph 2 * * page 481, column 2, paragraph 3 - page 482, column 1, paragraph 1 * * page 482, column 2, paragraph 2 *
 [X]  - HSU FENG-LIN ET AL, "Caffeic acid as active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats", PLANTA MEDICA, (200004), vol. 66, no. 3, ISSN 0032-0943, pages 228 - 230, XP008076263 [X] 1,3-5,7-9,14 * abstract * * page 228, column 1, paragraph 1 * * page 228, column 2, paragraph L - page 229, column 1, paragraph 3 * * page 229, column 2, paragraph 3 - page 230, column 1, paragraph 1 * * figures 1,2 *

DOI:   http://dx.doi.org/10.1055/s-2000-8561
 [X]  - FUWA T. ET AL., "Antidiabetic", DATABASE WPI, 0, Derwent World Patents Index, (19860802), no. 19, Database accession no. 1986-242356, page 7, XP002425375 & JPS61171418 A 19860802 (WAKUNAGA SEIYAKU KK) [X] 1,3-5,7-9,14-18 * column A *
 [X]  - KANO H. ET AL., "Food composition having inhibitory action on postprandial elevation of blood glucose.", DATABASE WPI, 0, Derwent World Patents Index, (20030422), no. 20, Database accession no. 2003-666734, page 3, XP002425376 & JP2003116486 A 20030422 (MEIJI MILK PROD CO LTD) [X] 1,3-5,7-9,14-18 * column A *
 [X]  - MATSUI T ET AL, "Anti-hyperglycemic potential of natural products", MINI-REVIEWS IN MEDICINAL CHEMISTRY 2006 NETHERLANDS, (2006), vol. 6, no. 3, ISSN 1389-5575, pages 349 - 356, XP008076264 [X] 1-5,7-9,14-18,20 * abstract * * page 350, column 1, paragraph 1 * * page 353, column 2, paragraph 1 * * figure 4 *

DOI:   http://dx.doi.org/10.2174/138955706776073484
 [X]  - STADLER, RICHARD H. ET AL, "The inhibitory effects of coffee on radical-mediated oxidation and mutagenicity", MUTATION RESEARCH , 308(2), 177-90 CODEN: MUREAV; ISSN: 0027-5107, (1994), XP002425368 [X] 15-17 * abstract * * page 178, column 2, paragraph 1 * * tables 1,2 * * page 187, column 2, paragraph L *

DOI:   http://dx.doi.org/10.1016/0027-5107(94)90153-8
 [A]  - BAILLY FABRICE ET AL, "Anti-HIV activities of natural antioxidant caffeic acid derivatives: Toward an antiviral supplementation diet", CURRENT MEDICINAL CHEMISTRY, (2005), vol. 12, no. 15, ISSN 0929-8673, pages 1811 - 1818, XP008076705 [A] * abstract * * page 1815, column 2, paragraph 2 - page 1816, column 1, paragraph L *

DOI:   http://dx.doi.org/10.2174/0929867054367239
 [X]  - SRI BALASUBASHINI M ET AL, "Protective effects of ferulic acid on hyperlipidemic diabetic rats.", ACTA DIABETOLOGICA, (200309), vol. 40, no. 3, ISSN 0940-5429, pages 118 - 122, XP002478246 [X] 1-4,7-9,14-18,20 * abstract * * page 119, column 1, paragraph 4 * * tables 1,2 * * page 121, column 1, paragraphs 5,6 * * page 121, column 2, paragraph 2 *

DOI:   http://dx.doi.org/10.1007/s00592-003-0099-6
 [X]  - KIM HAE KYUNG ET AL, "Lipid-lowering efficacy of hesperetin metabolites in high-cholesterol fed rats.", CLINICA CHIMICA ACTA, (200301), vol. 327, no. 1-2, ISSN 0009-8981, pages 129 - 137, XP002478247 [X] 1,3,14-18,20 * abstract * * figures 1,2 * * table 4 * * page 134, column 2, paragraph 3 * * page 136, column 1, paragraph 2 *

DOI:   http://dx.doi.org/10.1016/S0009-8981(02)00344-3
Examination   - TOUSCH D ET AL, "Chicoric acid, a new compound able to enhance insulin release and glucose uptake", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 377, no. 1, doi:10.1016/J.BBRC.2008.09.088, ISSN 0006-291X, (20081205), pages 131 - 135, (20081001), XP025587436

DOI:   http://dx.doi.org/10.1016/j.bbrc.2008.09.088
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.